Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13328505 | 0.84 | KDM4E (0.31) | ALDH1A1KDM4E | |
| SCHEMBL115296 | 0.80 | EPHX1 (0.40) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL26407314 | 0.80 | EPHX1 (0.40) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL19138721 | 0.80 | SHBG (0.36) | SHBGALDH1A1SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL28621311 | 0.79 | EPHX1 (0.39) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL9899213 | 0.78 | SMN1; SMN2 (0.39) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL1903296 | 0.74 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL19529529 | 0.73 | PDK1 (0.45) | SHBGALDH1A1SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL19529515 | 0.73 | PDK1 (0.45) | SHBGALDH1A1SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL19529501 | 0.73 | PDK1 (0.45) | SHBGALDH1A1SMN1; SMN2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2276452-B2 | PERFUMED COSMETIC PREPARATION CONTAINING CITRONELLOL | BEIERSDORF AG (DE) | 2022-01-05 | — | — | EP | claimed |
| EP-2276449-B2 | PERFUMED COSMETIC PREPARATION | BEIERSDORF AG (DE) | 2021-12-29 | — | — | EP | claimed |
| EP-2276449-B1 | PERFUMED COSMETIC PREPARATION | BEIERSDORF AG (DE) | 2016-09-21 | — | — | EP | claimed |
| EP-2276452-B1 | PERFUMED COSMETIC PREPARATION CONTAINING CITRONELLOL | BEIERSDORF AG (DE) | 2016-09-14 | — | — | EP | claimed |
| US-11072625-B2 | Highly potent multimeric e-selectin antagonists | GLYCOMIMETICS, INC. (US) | 2021-07-27 | — | — | US | disclosed |
| US-20190233458-A1 | HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS | GLYCOMIMETICS, INC. (US) | 2019-08-01 | — | — | US | disclosed |
| US-9719058-B2 | Fragrant oil encapsulation | PAPIERFABRIK AUGUST KOEHLER SE (DE) | 2017-08-01 | — | — | US | disclosed |
| US-20150210965-A1 | FRAGRANT OIL ENCAPSULATION | SYMRISE AG (DE) | 2015-07-30 | — | — | US | disclosed |
| US-20120308486-A1 | Fragrance and/or flavoring compositions containing dioxolanes | SYMRISE AG (DE) | 2012-12-06 | — | — | US | disclosed |
| US-20100310479-A1 | USE OF CERTAIN ISOPROPYL METHYLCYCLOHEXENE THIOLS AS FRAGRANCES AND/OR FLAVORS | SYMRISE GMBH & CO. KG (DE) | 2010-12-09 | — | — | US | disclosed |
| US-7368613-B2 | Sandal fragrances | SYMRISE GMBH & CO. KG (DE) | 2008-05-06 | — | — | US | disclosed |
| US-20070037733-A1 | Use of 3-cyclohexenyl-1-propanol as a fragrance | SYMRISE GMBH & CO. KG (DE) | 2007-02-15 | — | — | US | disclosed |
| US-20060281648-A1 | Sandal Fragrances | SYMRISE GMBH & CO. KG (DE) | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190233458-A1 | HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS | SELE, SELP, SELPLG | SHBG 248/4885ALDH1A1 759/4885SMN1; SMN2 2462/4885 |
| US-11072625-B2 | Highly potent multimeric e-selectin antagonists | SELE, SELP, SELPLG | SHBG 226/4885ALDH1A1 773/4885SMN1; SMN2 2259/4885 |
| US-20120308486-A1 | Fragrance and/or flavoring compositions containing dioxolanes | FDFT1, DECR1, DOHH | SHBG 1133/4885ALDH1A1 69/4885SMN1; SMN2 4042/4885 |
| US-20100310479-A1 | USE OF CERTAIN ISOPROPYL METHYLCYCLOHEXENE THIOLS AS FRAGRANCES AND/OR FLAVORS | TAS2R5, TAS2R1, TAS2R20 | SHBG 339/4885ALDH1A1 281/4885SMN1; SMN2 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.